Catalyst Wire Dossier Catalyst Wire Dossier

2-deoxyglucose

2-deoxyglucose
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 2-deoxyglucose, covering 2014-01-07 to 2014-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer [Phase 1, Phase 2]

See pricing